Twenty questions on atherosclerosis.
作者信息
Roberts W C
机构信息
Baylor Cardiovascular Institute, Baylor University Medical Center, Dallas, Texas 75246, USA.
出版信息
Proc (Bayl Univ Med Cent). 2000 Apr;13(2):139-43. doi: 10.1080/08998280.2000.11927657.
Abstract
摘要
相似文献
1
Twenty questions on atherosclerosis.关于动脉粥样硬化的二十个问题。
Proc (Bayl Univ Med Cent). 2000 Apr;13(2):139-43. doi: 10.1080/08998280.2000.11927657.
2
Atherosclerosis: Known and unknown.动脉粥样硬化：已知与未知
Pathol Int. 2022 Mar;72(3):151-160. doi: 10.1111/pin.13202. Epub 2022 Jan 25.
3
Imaging of subclinical atherosclerosis: questions and answers.亚临床动脉粥样硬化的影像学：问答
Curr Probl Diagn Radiol. 2011 May-Jun;40(3):116-26. doi: 10.1067/j.cpradiol.2010.02.003.
4
Coronary atherosclerosis in middle-aged athletes: Current insights, burning questions, and future perspectives.中年运动员的冠状动脉粥样硬化：当前的认识、热点问题和未来展望。
Clin Cardiol. 2020 Aug;43(8):863-871. doi: 10.1002/clc.23340. Epub 2020 Feb 7.
5
A DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombectomy.关于机械取栓治疗基础动脉粥样硬化所致颅内支架置入抗血小板管理的德尔菲共识声明
Neuroradiology. 2021 Apr;63(4):627-632. doi: 10.1007/s00234-020-02556-z. Epub 2020 Sep 24.
6
Genetic experimental preparations for studying atherosclerosis.用于研究动脉粥样硬化的基因实验制剂。
Prog Mol Biol Transl Sci. 2014;124:1-18. doi: 10.1016/B978-0-12-386930-2.00001-X.
7
The ultrastructure of animal atherosclerosis: what has been done, and the electron microscopy advancements that could help scientists answer new biological questions.动物动脉粥样硬化的超微结构：已完成的工作，以及可能帮助科学家回答新生物学问题的电子显微镜技术进展。
Micron. 2013 Mar;46:1-11. doi: 10.1016/j.micron.2012.12.001. Epub 2012 Dec 11.
8
The implications of neutrophil extracellular traps in the pathophysiology of atherosclerosis and atherothrombosis.中性粒细胞胞外诱捕网在动脉粥样硬化和动脉血栓形成病理生理学中的意义。
Exp Biol Med (Maywood). 2020 Sep;245(15):1376-1384. doi: 10.1177/1535370220945989. Epub 2020 Jul 29.
9
[Infection and atherosclerosis].
Vnitr Lek. 2007 Mar;53(3):286-91.
10
The 2013 ACC/AHA guidelines on the treatment of blood cholesterol: questions, questions, questions.2013年美国心脏病学会/美国心脏协会血液胆固醇治疗指南：问题，问题，还是问题。
Circ Res. 2014 Feb 28;114(5):761-4. doi: 10.1161/CIRCRESAHA.114.303398.
引用本文的文献
1
Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?人类射血分数保留型心力衰竭与猫心肌病：我们可以从兽医和人类医学中学到什么？
Heart Fail Rev. 2017 Nov;22(6):783-794. doi: 10.1007/s10741-017-9645-0.
2
Facts and ideas from anywhere.来自任何地方的事实与观点。
Proc (Bayl Univ Med Cent). 2017 Jul;30(3):384-390. doi: 10.1080/08998280.2017.11929658.
3
Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model.辛伐他汀预处理可预防兔模型中饮食诱导的动脉粥样硬化的发生。
Biomed Rep. 2016 Dec;5(6):667-674. doi: 10.3892/br.2016.780. Epub 2016 Oct 17.
本文引用的文献
1
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.4444例冠心病患者降胆固醇随机试验：斯堪的纳维亚辛伐他汀生存研究（4S）。1994年。
Atheroscler Suppl. 2004 Oct;5(3):81-7. doi: 10.1016/j.atherosclerosissup.2004.08.027.
2
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.血管紧张素转换酶抑制剂雷米普利对高危患者心血管事件的影响。
N Engl J Med. 2000 Jan 20;342(3):145-53. doi: 10.1056/NEJM200001203420301.
3
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.在稳定型冠状动脉疾病中，强化降脂治疗与血管成形术的比较。阿托伐他汀与血运重建治疗研究组。
N Engl J Med. 1999 Jul 8;341(2):70-6. doi: 10.1056/NEJM199907083410202.
4
Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I.高剂量辛伐他汀和阿托伐他汀对高密度脂蛋白胆固醇及载脂蛋白A-I的影响
Am J Cardiol. 1999 May 15;83(10):1476-7, A7. doi: 10.1016/s0002-9149(99)00153-8.
5
Dietary prevention of coronary heart disease: the Lyon Diet Heart Study.
Circulation. 1999 Feb 16;99(6):733-5. doi: 10.1161/01.cir.99.6.733.
6
Persistence of use of lipid-lowering medications: a cross-national study.降脂药物的持续使用：一项跨国研究。
JAMA. 1998 May 13;279(18):1458-62. doi: 10.1001/jama.279.18.1458.
7
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.共识声明：“他汀类药物”治疗在高甘油三酯血症患者中的作用
Am J Cardiol. 1998 Feb 26;81(4A):1B-6B. doi: 10.1016/s0002-9149(98)00030-7.
8
Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).阿托伐他汀与辛伐他汀、普伐他汀、洛伐他汀及氟伐他汀治疗高胆固醇血症患者的比较剂量疗效研究（CURVES研究）
Am J Cardiol. 1998 Mar 1;81(5):582-7. doi: 10.1016/s0002-9149(97)00965-x.
9
The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.他汀类药物降脂的“5规则”和“7规则”
Am J Cardiol. 1997 Jul 1;80(1):106-7.
10
Reductase inhibitor monotherapy and stroke prevention.还原酶抑制剂单一疗法与中风预防。
Arch Intern Med. 1997 Jun 23;157(12):1305-10.
Zotero 插件